These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 17074487

  • 1. Clinical predictors of steroid-induced exacerbation in myasthenia gravis.
    Bae JS, Go SM, Kim BJ.
    J Clin Neurosci; 2006 Dec; 13(10):1006-10. PubMed ID: 17074487
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM, Azem J, Fort JM, López-Cano M, Vilallonga R, Buera M, Cervera C, Armengol M.
    Neurology; 2005 May 10; 64(9):1641-3. PubMed ID: 15883336
    [Abstract] [Full Text] [Related]

  • 3. The treatment of severe forms of myasthenia gravis.
    Iani C, Caramia M, Morosetti M, Loberti M, Palmieri MG, Meloni C, Gallucci MT, Casciani CU, Bernardi G.
    Funct Neurol; 1998 May 10; 13(3):231-7. PubMed ID: 9800150
    [Abstract] [Full Text] [Related]

  • 4. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
    Stickler DE, Stickler LL.
    Muscle Nerve; 2007 Jun 10; 35(6):808-11. PubMed ID: 17221882
    [Abstract] [Full Text] [Related]

  • 5. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion.
    Fardet L, Flahault A, Kettaneh A, Tiev KP, Généreau T, Tolédano C, Lebbé C, Cabane J.
    Br J Dermatol; 2007 Jul 10; 157(1):142-8. PubMed ID: 17501951
    [Abstract] [Full Text] [Related]

  • 6. [Predictive factors of the response to treatment of myasthenia gravis with prednisone].
    Pradas J, Illa I.
    Neurologia; 1990 Jan 10; 5(1):11-3. PubMed ID: 2361025
    [Abstract] [Full Text] [Related]

  • 7. [Corticosteroids in the treatment of myasthenia gravis. Study of 12 cases with review of the literature].
    Lamartine de Assis J.
    Arq Neuropsiquiatr; 1975 Mar 10; 33(1):33-40. PubMed ID: 1164206
    [Abstract] [Full Text] [Related]

  • 8. Benefit from alternate-day prednisone in myasthenia gravis.
    Warmolts JR, Engel WK.
    N Engl J Med; 1972 Jan 06; 286(1):17-20. PubMed ID: 4331158
    [No Abstract] [Full Text] [Related]

  • 9. Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis.
    Kanzaki M, Obara T, Sasano S, Hikawa Y, Onuki T.
    Ann Thorac Cardiovasc Surg; 2008 Apr 06; 14(2):119-22. PubMed ID: 18414352
    [Abstract] [Full Text] [Related]

  • 10. Myasthenia gravis: diagnosis.
    Meriggioli MN, Sanders DB.
    Semin Neurol; 2004 Mar 06; 24(1):31-9. PubMed ID: 15229790
    [Abstract] [Full Text] [Related]

  • 11. [Exacerbation of myasthenia gravis by pefloxacin].
    Vial T, Chauplannaz G, Brunel P, Leriche B, Evreux JC.
    Rev Neurol (Paris); 1995 Apr 06; 151(4):286-7. PubMed ID: 7481384
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone.
    Shimojima Y, Matsuda M, Gono T, Ishii W, Tokuda T, Ikeda S.
    J Clin Neurosci; 2006 Jan 06; 13(1):39-44. PubMed ID: 16307880
    [Abstract] [Full Text] [Related]

  • 13. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y, Kawaguchi N, Hamada C, Sekiguchi H, Yasufuku K, Iyoda A, Shibuya K, Fujisawa T.
    Eur J Cardiothorac Surg; 2006 Jun 06; 29(6):908-13. PubMed ID: 16675232
    [Abstract] [Full Text] [Related]

  • 14. [Favorable results of plasmapheresis in severe myasthenia gravis].
    Blom RJ, Kuks JB, Westerterp-Maas A, Oosterhuis HJ.
    Ned Tijdschr Geneeskd; 1997 Feb 22; 141(8):381-4. PubMed ID: 9157298
    [Abstract] [Full Text] [Related]

  • 15. Eaton-Lambert myasthenic syndrome: long-term treatment of three patients with prednisone.
    Streib EW, Rothner AD.
    Ann Neurol; 1981 Nov 22; 10(5):448-53. PubMed ID: 6272625
    [Abstract] [Full Text] [Related]

  • 16. Influence of early high-dose steroid treatment on Bell's palsy evolution.
    Lagalla G, Logullo F, Di Bella P, Provinciali L, Ceravolo MG.
    Neurol Sci; 2002 Sep 22; 23(3):107-12. PubMed ID: 12391494
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
    Tüzün E, Saini SS, Ghosh S, Rowin J, Meriggioli MN, Christadoss P.
    Neuromuscul Disord; 2006 Feb 22; 16(2):137-43. PubMed ID: 16427283
    [Abstract] [Full Text] [Related]

  • 18. Longstanding right-hand weakness in a patient with myasthenia gravis.
    de Carvalho M, Geraldes R.
    Muscle Nerve; 2006 Nov 22; 34(5):670-1. PubMed ID: 16878322
    [No Abstract] [Full Text] [Related]

  • 19. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
    Liu C, Gui M, Cao Y, Lin J, Li Y, Ji S, Bu B.
    Pediatr Neurol; 2017 Dec 22; 77():42-47. PubMed ID: 29074055
    [Abstract] [Full Text] [Related]

  • 20. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
    Ponseti JM, Gamez J, Azem J, Fort JM, López-Cano M, Vilallonga R, Buera M, Armengol M.
    Curr Med Res Opin; 2007 Jun 22; 23(6):1269-78. PubMed ID: 17559724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.